LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 127

Search options

  1. Article ; Online: Osteogenesis Imperfecta: Mechanisms and Signaling Pathways Connecting Classical and Rare OI Types.

    Jovanovic, Milena / Guterman-Ram, Gali / Marini, Joan C

    Endocrine reviews

    2021  Volume 43, Issue 1, Page(s) 61–90

    Abstract: ... involved in their pathophysiology. There is a special emphasis on mutations in type I procollagen C ...

    Abstract Osteogenesis imperfecta (OI) is a phenotypically and genetically heterogeneous skeletal dysplasia characterized by bone fragility, growth deficiency, and skeletal deformity. Previously known to be caused by defects in type I collagen, the major protein of extracellular matrix, it is now also understood to be a collagen-related disorder caused by defects in collagen folding, posttranslational modification and processing, bone mineralization, and osteoblast differentiation, with inheritance of OI types spanning autosomal dominant and recessive as well as X-linked recessive. This review provides the latest updates on OI, encompassing both classical OI and rare forms, their mechanism, and the signaling pathways involved in their pathophysiology. There is a special emphasis on mutations in type I procollagen C-propeptide structure and processing, the later causing OI with strikingly high bone mass. Types V and VI OI, while notably different, are shown to be interrelated by the interferon-induced transmembrane protein 5 p.S40L mutation that reveals the connection between the bone-restricted interferon-induced transmembrane protein-like protein and pigment epithelium-derived factor pathways. The function of regulated intramembrane proteolysis has been extended beyond cholesterol metabolism to bone formation by defects in regulated membrane proteolysis components site-2 protease and old astrocyte specifically induced-substance. Several recently proposed candidate genes for new types of OI are also presented. Discoveries of new OI genes add complexity to already-challenging OI management; current and potential approaches are summarized.
    MeSH term(s) Collagen/genetics ; Collagen Type I/genetics ; Collagen Type I/metabolism ; Humans ; Interferons/genetics ; Mutation ; Osteogenesis Imperfecta/genetics ; Osteogenesis Imperfecta/metabolism ; Signal Transduction
    Chemical Substances Collagen Type I ; Collagen (9007-34-5) ; Interferons (9008-11-1)
    Language English
    Publishing date 2021-05-17
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Review
    ZDB-ID 603096-8
    ISSN 1945-7189 ; 0163-769X
    ISSN (online) 1945-7189
    ISSN 0163-769X
    DOI 10.1210/endrev/bnab017
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Pulmonary function and structure abnormalities in children and young adults with osteogenesis imperfecta point to intrinsic and extrinsic lung abnormalities.

    Gochuico, Bernadette R / Hossain, Mahin / Talvacchio, Sara K / Zuo, Mei Xing G / Barton, Mark / Dang Do, An Ngoc / Marini, Joan C

    Journal of medical genetics

    2023  Volume 60, Issue 11, Page(s) 1067–1075

    Abstract: Purpose: Pulmonary disease is the major cause of morbidity and mortality in osteogenesis imperfecta (OI). We investigated the contribution of intrinsic lung factors to impaired pulmonary function in children and young adults with OI types III, IV, VI.!## ...

    Abstract Purpose: Pulmonary disease is the major cause of morbidity and mortality in osteogenesis imperfecta (OI). We investigated the contribution of intrinsic lung factors to impaired pulmonary function in children and young adults with OI types III, IV, VI.
    Methods: Patients with type III (n=8), IV (n=21), VI (n=5), VII (n=2) or XIV (n=1) OI (mean age 23.6 years) prospectively underwent pulmonary function tests (PFTs) and thoracic CT and radiographs.
    Results: PFT results were similar using arm span or ulnar length as height surrogates. PFTs were significantly lower in type III than type IV or VI OI. All patients with type III and half of type IV OI had lung restriction; 90% of patients with OI had reduced gas exchange. Patients with
    Conclusion: Both lung intrinsic and extrinsic skeletal abnormalities contribute to OI pulmonary dysfunction. Most young adult patients have restrictive disease and abnormal gas exchange; impairment is greater in type III than type IV OI. Decreased FEF25%-75% and thickening of small bronchi walls indicate a critical role for small airways. Lung parenchymal abnormalities (atelectasis, reticulations) and pleural thickening were also detected. Clinical interventions to mitigate these impairments are warranted.
    Trial registration number: NCT03575221.
    Language English
    Publishing date 2023-05-16
    Publishing country England
    Document type Journal Article
    ZDB-ID 220881-7
    ISSN 1468-6244 ; 0022-2593
    ISSN (online) 1468-6244
    ISSN 0022-2593
    DOI 10.1136/jmg-2022-109009
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: CaMKII inhibition due to TRIC-B loss-of-function dysregulates SMAD signaling in osteogenesis imperfecta.

    Besio, Roberta / Contento, Barbara M / Garibaldi, Nadia / Filibian, Marta / Sonntag, Stephan / Shmerling, Doron / Tonelli, Francesca / Biggiogera, Marco / Brini, Marisa / Salmaso, Andrea / Jovanovic, Milena / Marini, Joan C / Rossi, Antonio / Forlino, Antonella

    Matrix biology : journal of the International Society for Matrix Biology

    2023  Volume 120, Page(s) 43–59

    Abstract: ... ...

    Abstract Ca
    MeSH term(s) Animals ; Mice ; Osteogenesis Imperfecta/genetics ; Osteogenesis Imperfecta/metabolism ; Calcium-Calmodulin-Dependent Protein Kinase Type 2/genetics ; Calcium-Calmodulin-Dependent Protein Kinase Type 2/metabolism ; Ion Channels/genetics ; Ion Channels/metabolism ; Osteogenesis ; Collagen/metabolism ; Osteoblasts ; Cations/metabolism
    Chemical Substances Calcium-Calmodulin-Dependent Protein Kinase Type 2 (EC 2.7.11.17) ; Ion Channels ; Collagen (9007-34-5) ; Cations ; TRIC-B protein, mouse
    Language English
    Publishing date 2023-05-11
    Publishing country Netherlands
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1183793-7
    ISSN 1569-1802 ; 0945-053X
    ISSN (online) 1569-1802
    ISSN 0945-053X
    DOI 10.1016/j.matbio.2023.05.002
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Antagonism Between PEDF and TGF-β Contributes to Type VI Osteogenesis Imperfecta Bone and Vascular Pathogenesis.

    Kang, Heeseog / Aryal Ac, Smriti / Barnes, Aileen M / Martin, Aline / David, Valentin / Crawford, Susan E / Marini, Joan C

    Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

    2022  Volume 37, Issue 5, Page(s) 925–937

    Abstract: Osteogenesis imperfecta (OI) is a heterogeneous genetic disorder of bone and connective tissue, also known as brittle bone disease. Null mutations in SERPINF1, which encodes pigment epithelium-derived factor (PEDF), cause severe type VI OI, characterized ...

    Abstract Osteogenesis imperfecta (OI) is a heterogeneous genetic disorder of bone and connective tissue, also known as brittle bone disease. Null mutations in SERPINF1, which encodes pigment epithelium-derived factor (PEDF), cause severe type VI OI, characterized by accumulation of unmineralized osteoid and a fish-scale pattern of bone lamellae. Although the potent anti-angiogenic activity of PEDF has been extensively studied, the disease mechanism of type VI OI is not well understood. Using Serpinf1
    MeSH term(s) Animals ; Endothelial Cells ; Eye Proteins/genetics ; Eye Proteins/metabolism ; Mice ; Nerve Growth Factors/genetics ; Nerve Growth Factors/metabolism ; Osteogenesis Imperfecta/genetics ; Osteogenesis Imperfecta/metabolism ; Serpins/genetics ; Serpins/metabolism ; Transforming Growth Factor beta/genetics ; Transforming Growth Factor beta/metabolism
    Chemical Substances Eye Proteins ; Nerve Growth Factors ; Serpins ; Transforming Growth Factor beta ; pigment epithelium-derived factor
    Language English
    Publishing date 2022-04-13
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural ; Research Support, N.I.H., Intramural
    ZDB-ID 632783-7
    ISSN 1523-4681 ; 0884-0431
    ISSN (online) 1523-4681
    ISSN 0884-0431
    DOI 10.1002/jbmr.4540
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article: SMAD3

    El-Gazzar, Ahmed / Kang, Heeseog / Fratzl-Zelman, Nadja / Webb, Emma / Barnes, Aileen M / Jovanovic, Milena / Mehta, Sarju G / Datta, Vipan / Saraff, Vrinda / Dale, Ryan K / Rauch, Frank / Marini, Joan C / Högler, Wolfgang

    Bone reports

    2022  Volume 17, Page(s) 101603

    Abstract: Loss-of-function mutations ... ...

    Abstract Loss-of-function mutations in
    Language English
    Publishing date 2022-07-16
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2821774-3
    ISSN 2352-1872
    ISSN 2352-1872
    DOI 10.1016/j.bonr.2022.101603
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Dissecting the phenotypic variability of osteogenesis imperfecta.

    Garibaldi, Nadia / Besio, Roberta / Dalgleish, Raymond / Villani, Simona / Barnes, Aileen M / Marini, Joan C / Forlino, Antonella

    Disease models & mechanisms

    2022  Volume 15, Issue 5

    Abstract: Osteogenesis imperfecta (OI) is a heterogeneous family of collagen type I-related diseases characterized by bone fragility. OI is most commonly caused by single-nucleotide substitutions that replace glycine residues or exon splicing defects in the COL1A1 ...

    Abstract Osteogenesis imperfecta (OI) is a heterogeneous family of collagen type I-related diseases characterized by bone fragility. OI is most commonly caused by single-nucleotide substitutions that replace glycine residues or exon splicing defects in the COL1A1 and COL1A2 genes that encode the α1(I) and α2(I) collagen chains. Mutant collagen is partially retained intracellularly, impairing cell homeostasis. Upon secretion, it assembles in disorganized fibrils, altering mineralization. OI is characterized by a wide range of clinical outcomes, even in the presence of identical sequence variants. Given the heterotrimeric nature of collagen I, its amino acid composition and the peculiarity of its folding, several causes may underlie the phenotypic variability of OI. A deep analysis of entries regarding glycine and splice site collagen substitution of the largest publicly available patient database reveals a higher risk of lethal phenotype for carriers of variants in α1(I) than in α2(I) chain. However, splice site variants are predominantly associated with lethal phenotype when they occur in COL1A2. In addition, lethality is increased when mutations occur in regions of importance for extracellular matrix interactions. Both extracellular and intracellular determinants of OI clinical severity are discussed in light of the findings from in vitro and in vivo OI models. Combined with meticulous tracking of clinical cases via a publicly available database, the available OI animal models have proven to be a unique tool to shed light on new modulators of phenotype determination for this rare heterogeneous disease.
    MeSH term(s) Animals ; Biological Variation, Population ; Collagen/metabolism ; Collagen Type I, alpha 1 Chain ; Glycine/genetics ; Humans ; Mutation/genetics ; Osteogenesis Imperfecta/genetics ; Phenotype
    Chemical Substances Collagen Type I, alpha 1 Chain ; Collagen (9007-34-5) ; Glycine (TE7660XO1C)
    Language English
    Publishing date 2022-05-16
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't ; Research Support, N.I.H., Extramural
    ZDB-ID 2451104-3
    ISSN 1754-8411 ; 1754-8403
    ISSN (online) 1754-8411
    ISSN 1754-8403
    DOI 10.1242/dmm.049398
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Book: Recessive osteogenesis imperfecta is collagen-related

    Marini, Joan C

    (CC grand rounds)

    2013  

    Title variant Procollagen misfolding in bone disorders
    Institution National Institutes of Health (U.S.). / Clinical Center
    Author's details Joan C. Marini. Procollagen misfolding in bone disorders / Sergey Leikin
    Series title CC grand rounds
    MeSH term(s) Osteogenesis Imperfecta/physiopathology ; Collagen Diseases/physiopathology ; Procollagen ; Proteostasis Deficiencies
    Language English
    Size 1 online resource (1 streaming video file (54 min.) :, sd., col.)
    Publisher National Institutes of Health
    Publishing place Bethesda, Md
    Document type Book
    Note Closed-captioned.
    Database Catalogue of the US National Library of Medicine (NLM)

    More links

    Kategorien

  8. Article ; Online: Absence of TRIC-B from type XIV Osteogenesis Imperfecta osteoblasts alters cell adhesion and mitochondrial function - A multi-omics study.

    Jovanovic, Milena / Mitra, Apratim / Besio, Roberta / Contento, Barbara Maria / Wong, Ka Wai / Derkyi, Alberta / To, Michael / Forlino, Antonella / Dale, Ryan K / Marini, Joan C

    Matrix biology : journal of the International Society for Matrix Biology

    2023  Volume 121, Page(s) 127–148

    Abstract: Osteogenesis Imperfecta (OI) is a heritable collagen-related bone dysplasia characterized by bone fractures, growth deficiency and skeletal deformity. Type XIV OI is a recessive OI form caused by null mutations in TMEM38B, which encodes the ER membrane ... ...

    Abstract Osteogenesis Imperfecta (OI) is a heritable collagen-related bone dysplasia characterized by bone fractures, growth deficiency and skeletal deformity. Type XIV OI is a recessive OI form caused by null mutations in TMEM38B, which encodes the ER membrane intracellular cation channel TRIC-B. Previously, we showed that absence of TMEM38B alters calcium flux in the ER of OI patient osteoblasts and fibroblasts, which further disrupts collagen synthesis and secretion. How the absence of TMEM38B affects osteoblast function is still poorly understood. Here we further investigated the role of TMEM38B in human osteoblast differentiation and mineralization. TMEM38B-null osteoblasts showed altered expression of osteoblast marker genes and decreased mineralization. RNA-Seq analysis revealed that cell-cell adhesion was one of the most downregulated pathways in TMEM38B-null osteoblasts, with further validation by real-time PCR and Western blot. Gap and tight junction proteins were also decreased by TRIC-B absence, both in patient osteoblasts and in calvarial osteoblasts of Tmem38b-null mice. Disrupted cell adhesion decreased mutant cell proliferation and cell cycle progression. An important novel finding was that TMEM38B-null osteoblasts had elongated mitochondria with altered fusion and fission markers, MFN2 and DRP1. In addition, TMEM38B-null osteoblasts exhibited a significant increase in superoxide production in mitochondria, further supporting mitochondrial dysfunction. Together these results emphasize the novel role of TMEM38B/TRIC-B in osteoblast differentiation, affecting cell-cell adhesion processes, gap and tight junction, proliferation, cell cycle, and mitochondrial function.
    MeSH term(s) Animals ; Humans ; Mice ; Cell Adhesion ; Collagen/metabolism ; Ion Channels/genetics ; Ion Channels/metabolism ; Multiomics ; Osteoblasts ; Osteogenesis/genetics ; Osteogenesis Imperfecta/genetics ; Osteogenesis Imperfecta/metabolism
    Chemical Substances Collagen (9007-34-5) ; Ion Channels ; TRIC-B protein, mouse ; TMEM38B protein, human
    Language English
    Publishing date 2023-06-20
    Publishing country Netherlands
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 1183793-7
    ISSN 1569-1802 ; 0945-053X
    ISSN (online) 1569-1802
    ISSN 0945-053X
    DOI 10.1016/j.matbio.2023.06.004
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Bone: Use of bisphosphonates in children-proceed with caution.

    Marini, Joan C

    Nature reviews. Endocrinology

    2009  Volume 5, Issue 5, Page(s) 241–243

    Abstract: A clinical review of studies on bisphosphonate therapy for pediatric osteoporosis has revealed that they increase BMD, but whether they also improve fracture rates or functions of daily life is unclear. Can the findings of this clinical review help ... ...

    Abstract A clinical review of studies on bisphosphonate therapy for pediatric osteoporosis has revealed that they increase BMD, but whether they also improve fracture rates or functions of daily life is unclear. Can the findings of this clinical review help inform clinicians whether, when and how to use these agents in children?
    MeSH term(s) Bone Density/drug effects ; Child ; Diphosphonates/adverse effects ; Diphosphonates/pharmacology ; Diphosphonates/therapeutic use ; Humans ; Osteoporosis/drug therapy
    Chemical Substances Diphosphonates
    Language English
    Publishing date 2009-05-14
    Publishing country England
    Document type News
    ZDB-ID 2489381-X
    ISSN 1759-5037 ; 1759-5029
    ISSN (online) 1759-5037
    ISSN 1759-5029
    DOI 10.1038/nrendo.2009.58
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Osteogenesis imperfecta.

    Forlino, Antonella / Marini, Joan C

    Lancet (London, England)

    2015  Volume 387, Issue 10028, Page(s) 1657–1671

    Abstract: Osteogenesis imperfecta is a phenotypically and molecularly heterogeneous group of inherited connective tissue disorders that share similar skeletal abnormalities causing bone fragility and deformity. Previously, the disorder was thought to be an ... ...

    Abstract Osteogenesis imperfecta is a phenotypically and molecularly heterogeneous group of inherited connective tissue disorders that share similar skeletal abnormalities causing bone fragility and deformity. Previously, the disorder was thought to be an autosomal dominant bone dysplasia caused by defects in type I collagen, but in the past 10 years discoveries of novel (mainly recessive) causative genes have lent support to a predominantly collagen-related pathophysiology and have contributed to an improved understanding of normal bone development. Defects in proteins with very different functions, ranging from structural to enzymatic and from intracellular transport to chaperones, have been described in patients with osteogenesis imperfecta. Knowledge of the specific molecular basis of each form of the disorder will advance clinical diagnosis and potentially stimulate targeted therapeutic approaches. In this Seminar, together with diagnosis, management, and treatment, we describe the defects causing osteogenesis imperfecta and their mechanism and interrelations, and classify them into five groups on the basis of the metabolic pathway compromised, specifically those related to collagen synthesis, structure, and processing; post-translational modification; folding and cross-linking; mineralisation; and osteoblast differentiation.
    MeSH term(s) Bone Density Conservation Agents/therapeutic use ; Calcification, Physiologic/genetics ; Cell Differentiation/genetics ; Collagen Type I/genetics ; Disease Management ; Genetic Predisposition to Disease ; Humans ; Mutation ; Osteoblasts/pathology ; Osteogenesis/genetics ; Osteogenesis Imperfecta/diagnosis ; Osteogenesis Imperfecta/genetics ; Osteogenesis Imperfecta/therapy ; Protein Processing, Post-Translational/genetics
    Chemical Substances Bone Density Conservation Agents ; Collagen Type I
    Language English
    Publishing date 2015-11-03
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Intramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    DOI 10.1016/S0140-6736(15)00728-X
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top